Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding

References

• Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, et al. Development of humanized antibodies as cancer therapeutics. Methods 2005; 36:84 - 95; PMID: 15848077; http://dx.doi.org/10.1016/j.ymeth.2005.01.008
   PubMed Web of Science ®Google Scholar
• Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343 - 357; http://dx.doi.org/10.1038/nri1837
   PubMed Web of Science ®Google Scholar
• Hale G. Therapeutic antibodies—Delivering the promise?. Adv Drug Deliv Rev 2006; 58:633 - 639; PMID: 16822575; http://dx.doi.org/10.1016/j.addr.2006.03.010
   PubMed Web of Science ®Google Scholar
• Mather JP. Engineered antibody therapeutics. Adv Drug Deliv Rev 2006; 58:631 - 632; PMID: 16857292; http://dx.doi.org/10.1016/j.addr.2006.05.001
   PubMed Web of Science ®Google Scholar
• Wang W, Singh S, Zeng DL, King K, Nema S. Antibody structure, instability and formulation. J Pharm Sci 2007; 96:1 - 26; PMID: 16998873; http://dx.doi.org/10.1002/jps.20727
   PubMed Web of Science ®Google Scholar
• Daugherty AL, Mrsny RJ. Formulation and delivery issues for monoclonal antibody therapeutics. Adv Drug Deliv Rev 2006; 58:686 - 706; PMID: 16839640; http://dx.doi.org/10.1016/j.addr.2006.03.011
   PubMed Web of Science ®Google Scholar
• Kayser V, Chennamsetty N, Voynov V, Helk B, Forrer K, Trout BL. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation. J Pharm Sci 2011; 100:2526 - 2542; PMID: 21268027; http://dx.doi.org/10.1002/jps.22493
   PubMed Web of Science ®Google Scholar
• Bee JS, Davis M, Freund E, Carpenter JF, Randolph TW. Aggregation of a monoclonal antibody induced by adsorption to stainless steel. Biotechnol Bioeng 2009; 105:121 - 129; PMID: 19725039; http://dx.doi.org/10.1002/bit.22525
   PubMed Web of Science ®Google Scholar
• Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G. Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: Essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharm Sci 2010; 99:2200 - 2208; PMID: 19918982; http://dx.doi.org/10.1002/jps.21989
   PubMed Web of Science ®Google Scholar
• Stryer L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin: A fluorescent probe of non-polar binding sites. J Mol Biol 1965; 13:482 - 495; PMID: 5867031; http://dx.doi.org/10.1016/S0022-2836(6aev5)80111-5
   PubMedGoogle Scholar
• Semisotnov GV, Rodionova NA, Razguly OI, Uversky VN, Gripas' AF, Gilmanshin RI. Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 1991; 31:119 - 128; PMID: 2025683; http://dx.doi.org/10.1002/bip.360310111
   PubMed Web of Science ®Google Scholar
• Levine HI. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci 1993; 2:404 - 410; PMID: 8453378; http://dx.doi.org/10.1002/pro.5560020312
   PubMed Web of Science ®Google Scholar
• He F, Hogan S, Latypov RF, Narhi LO, Razinkov VI. High throughput thermostability screening of monoclonal antibody formulations. J Pharm Sci 2010; 99:1707 - 1720; PMID: 19780136; http://dx.doi.org/10.1002/jps.21955
   PubMed Web of Science ®Google Scholar
• Demeule B, Lawrence MJ, Drake AF, Gurny R, Arvinte T. Characterization of protein aggregation: The case of a therapeutic immunoglobulin. Biochim Biophys Acta 2007; 1774:146 - 153; PMID: 17142116; http://dx.doi.org/10.1016/j.bbapap.2006.10.010
   PubMed Web of Science ®Google Scholar
• Hawe A, Friess W, Sutter M, Jiskoot W. Online fluorescent dye detection method for the characterization of immunoglobulin G aggregation by size exclusion chromatography and asymmetrical flow field flow fractionation. Anal Biochem 2008; 378:115 - 122; PMID: 18455994; http://dx.doi.org/10.1016/j.ab.2008.03.050
   PubMed Web of Science ®Google Scholar
• He F, Phan DH, Hogan S, Bailey R, Becker GW, Narhi LO, et al. Detection of IgG aggregation by a high throughput method based on extrinsic fluorescence. J Pharm Sci 2010; 99:2598 - 2608; PMID: 20039384; http://dx.doi.org/10.1002/jps.22036
   PubMed Web of Science ®Google Scholar
• Demeule B, Palais C, Machaidze G, Gurny R, Arvinte T. New methods allowing the detection of protein aggregates: A case study on trastuzumab. mAbs 2009; 1:142 - 150; http://dx.doi.org/10.4161/mabs.1.2.7632
   PubMed Web of Science ®Google Scholar
• Daniel E, Weber G. Cooperative effects in binding by bovine serum albumin. I. The binding of 1-Anilino-8-naphthalenesulfonate. Fluorimetric titrations. Biochemistry 1966; 5:1893 - 1900; http://dx.doi.org/10.1021/bi00870a016
   PubMed Web of Science ®Google Scholar
• Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci 1998; 95:4224 - 4228; PMID: 9539718
   PubMed Web of Science ®Google Scholar
• Van Nuland NAJ, Meijberg W, Warner J, Forge V, Scheek RM, Robillard GT, et al. Slow cooperative folding of a small globular protein HPr. Biochemistry 1998; 37:622 - 637; PMID: 9425085; http://dx.doi.org/10.1021/bi9717946
   PubMed Web of Science ®Google Scholar
• Chang Ls, Wen Ey, Hung Jj, Chang Cc. Energy transfer from tryptophan residues of proteins to 8-anilinonaphthalene-1-sulfonate. Protein J 1994; 13:635 - 640; PMID: 7702745; http://dx.doi.org/10.1007/BF01890462
   PubMed Web of Science ®Google Scholar
• Pedersen S, Nesgaard L, Baptista RP, Melo EP, Kristensen SR, Otzen DE. pH-dependent aggregation of cutinase is efficiently suppressed by 1,8-ANS. Biopolymers 2006; 83:619 - 629; PMID: 16964599; http://dx.doi.org/10.1002/bip.20598
   PubMed Web of Science ®Google Scholar
• Biancalana M, Makabe K, Koide A, Koide S. Molecular mechanism of Thioflavin-T binding to the surface of β-rich peptide self-assemblies. J Mol Biol 2009; 385:1052 - 1063; PMID: 19038267; http://dx.doi.org/10.1016/j.jmb.2008.11.006
   PubMed Web of Science ®Google Scholar
• Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, et al. Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol 2005; 151:229 - 238; PMID: 16125973; http://dx.doi.org/10.1016/j.jsb.2005.06.006
   PubMed Web of Science ®Google Scholar
• LeVine H, Ronald W. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 1999; 309:274 - 284; PMID: 10507030; http://dx.doi.org/10.1016/S0076-6879(99)09020-5
   PubMed Web of Science ®Google Scholar
• Roberts CJ. Kinetics of irreversible protein aggregation: Analysis of extended Lumry-Eyring models and implications for predicting protein shelf life. J Phys Chem B 2003; 107:1194 - 1207; http://dx.doi.org/10.1021/jp026827s
   Web of Science ®Google Scholar
• Murphy RM, Tsai AM. Misbehaving proteins: protein (mis)folding, aggregation and stability 2006; New York Springer Science + Business Media, LLC
   Google Scholar